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INTRODUCTION
Cancer has become a major public health concern in 
Algeria. In a recent retrospective study, we have found that 
the age-standardized incidence for all cancers in women 
was 27.8 per 100,000 and that for males was 23.6 per 
100,000. Moreover, we have reported that breast cancer 
was the most frequent malignancy in North West Algerian 
women (36.9% of the total female cancers) (Benarba et al., 
2014a). In another study, we found that about 80% of 
Algerian breast cancer postmenopausal women enrolled 
into the study had used medicinal plants to manage 
and/or treat their illness (Benarba et al., 2014b). Although 
this reality, few studies have been undertaken to study the 
ethnomedicinal uses of medicinal plants used as anticancer 
treatments in Algeria.
Bryonia dioica Jacq. is a climbing perennial herb with 
tuberous roots. The plant, locally named in Algeria “Fachira,” 
is widely used in Algeria to treat several diseases. The roots 
of B. dioica are characterized by the presence of some 
bioactive compounds such as cucurbitacins and flavonols are 
possessing anticancer activities (Seo et al., 2014).
The present study aimed to document the ethnomedicinal 
uses of B. dioica in Mascara (North West Algeria).
MATERIALS AND METHODS
The ethnobotanical investigation was carried out in 
Mascara Province. Mascara (5941 km²) is located in 
the north west of Algeria, (at 360 km of Algiers) with 
Mediterranean climate and mean annual precipitations of 
about 450 mm. In 2010, the total population was 826334, 
with male/female ratio of about 1.04 (Benarba et al., 
2014). Ethnomedicinal uses of B. dioica information were 
collected and documented through casual conversations 
and semi-structured interview technique (Rajakumar 
and Shivanna, 2009) with local herbal practitioners and 
knowledgeable residents of the study area. The main 
focus was to collect the oral information about the 
ethnomedicinal uses of B. dioica by the local population.
RESULTS
The ethnobotanical survey we conducted to document the 
ethnomedicinal uses of B. dioica by the local population 
of Mascara province revealed that almost all of the 
respondents knew and/or used B. dioica for medicinal 
purposes.
Roots the only plant part used locally are used to treat 
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Bryonia dioica (Cucurbitaceae), a climbing perennial herb, is widely used in traditional medicine in Algeria. The 
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findings suggest that B. dioica could be considered as a promising source for developing novel therapeutics 
against breast cancer.
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(18%), fertility disorders (14%), and other ailments 
[Figure 1]. From all cancers, the plant is mainly prescribed 
to treat breast cancer (92%). Some data (unverified) 
reported several cases of “total healing.”
With regard to the method of preparation [Figure 2], 
B. dioica roots are taken orally, alone or mixed with different 
ingredients of non-plant origin such as water or honey to 
treat internal ailments such as cancer, diabetes, or fertility 
disorders. Roots are also applied externally for rheumatism.
DISCUSSION
Ethnopharmacological knowledge is beneficial in guiding 
which plants may have potentials to be used as source of 
anticancer products (Siriwatanametanon et al., 2010). 
Although local populations in Africa still use medicinal 
plants to treat cancers, ethnopharmacological studies from 
African medicinal plants has not been realized as fully as 
from other traditional societies such as India and China 
(Ashidi et al., 2010).
The purpose of the present study was to record the 
ethnomedicinal uses of B. dioica. The latter is widely used in 
Algeria to treat several pathologies. Our results showed that 
the first ailment treated by the local population in mascara 
province using B. dioica was the breast cancer. On the 
other hand, roots of B. dioica are considered as antidiabetic 
in local “phytotherapy.” The plant is similarly used in 
Jordan (Mahasneh and El-Oqlah, 1999) and in Armenia 
(Karageuzyan et al., 1998). Fruits of B. dioica are not used 
by local population because of their toxicity, mainly due to 
triterpene glucosides and calcium oxalate crystals (Barreira 
et al., 2013). We have demonstrated that an aqueous extract 
of B. dioica roots was able to induce cell death in two 
aggressive breast cancer cell lines: MDA-MB-231 and HBL-
100 (data not published). The cell death was accompanied 
apoptosis induction and cell cycle arrest at G2/M phase. 
Previously, we have reported that B. dioica aqueous extract 
induced apoptosis through the intrinsic (mitochondrial) 
pathway in Burkitt’s lymphoma BL51 cell line (Benarba et 
al., 2012). The use of B. dioica roots as an anti-breast cancer 
treatment by local populations in North West Algeria may 
be attributed to its major bioactive compound: Kempferol 
3, 7-di-O-rhamnoside (Barros et al., 2011). Indeed, it has 
been reported that kempferol and kempferol glycosides 
induced cell death and apoptosis of breast cancer cell lines 
(Ibrahim et al., 2008; Diantini et al., 2012).
CONCLUSION
We present evidence that B. dioica is widely used by the 
local populations of mascara province (West Algeria) to 
treat several ailments such as cancer and diabetes. Breast 
cancer remains the first disease to be treated with B. dioica. 
Roots of the plant are commonly used mixed with honey.
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